ArticleInflammation2026
The Histamine Four Receptor Regulates LFA-1 But Not Mac-1 -Dependent Neutrophil Adhesion and Inflammatory Functions.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neutrophils incubated on ICAM-1- or fibrinogen- coated plates produced histamine in response to fMLP indicating that histamine may be an intermediary chemoattractant promoting β2 integrin-dependent adhesion. fMLP, but not histamine or the histamine four receptor (H4R) agonist VUF 8430, augmented adhesion of neutrophils, or neutrophil-like PLB-985 cells, to fibrinogen, a Mac-1 ligand. This result may be explained by the fact that fMLP, but not histamine, augmented intracellular calcium, a pre-requisite for Mac-1 expression on the cell surface. fMLP- induced Mac-1- dependent adhesion was not affected by histamine or VUF 8430. fMLP induces conformational activation of LFA-1, but neutrophil adhesion to ICAM-1 was not augmented by fMLP. Histamine did not augment neutrophil adhesion to ICAM-1, as histamine does not induce conformational activation of LFA-1. Importantly, fMLP augmented neutrophil adhesion to ICAM-1 when combined with histamine or VUF 8430. Thus, activation of the H4R and the formyl peptide receptor 1 may be required to augment LFA-1 avidity. Histamine activated Rap1, Rac1/2 and Cdc42 in neutrophil-like PLB-985 cells. These effects were blocked by Src tyrosine kinase inhibitors (for Rap1 and Rac1/2 but not Cdc42). VUF 8430 activated these GTPases in PLB-985 cells and neutrophils indicating that the H4R controls neutrophil functions. Intriguingly, histamine inhibited fMLP-induced specific granule but not azurophil granule exocytosis by adherent neutrophils. Histaminase is present in specific granules. Therefore, inhibition of specific granule exocytosis may be a mechanism to limit the catabolism of histamine produced by adherent neutrophils to allow H4R-mediated inflammation through activation of monomeric GTPases and LFA-1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.